Abstract
Impulse control disorders (ICD) can be triggered by dopamine replacement therapies in patients with Parkinson's Disease (PD). Previous studies have identified several risk factors associated with ICD. In this study we investigated the presence of white matter (WM) microstructural changes at baseline in a cohort of drug-naïve PD patients who successively developed ICD over a 36-month follow-up period (ICD+) compared with patients who did not (ICD-).
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have